Comerica Bank’s Cullinan Oncology CGEM Stock Holding History

Comerica Bank’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$683	Sell	66 -129	-66%	-$1.16K	﹤0.01%	3612
2025 Q3	$1.16K	Buy	195 +50	+34%	+$366	﹤0.01%	3580
2025 Q2	$1.09K	Buy	145 +124	+590%	+$996	﹤0.01%	3574
2025 Q1	$159	Sell	21 -116	-85%	-$1.11K	﹤0.01%	3652
2024 Q4	$1.67K	Hold	137	–	–	﹤0.01%	3510
2024 Q3	$2.29K	Hold	137	–	–	﹤0.01%	3476
2024 Q2	$2.39K	Buy	137 +15	+12%	+$319	﹤0.01%	3460
2024 Q1	$2.08K	Hold	122	–	–	﹤0.01%	3526
2023 Q4	$1.24K	Hold	122	–	–	﹤0.01%	3599
2023 Q3	$1.1K	Buy	+122	New	+$1.27K	﹤0.01%	3650

Other funds holding CGEM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Comerica Bank's CGEM Position: Q4 2025 in Review

Comerica Bank reduced its Cullinan Oncology (CGEM) stake by 66% in Q4 2025, selling an estimated $1.16K and leaving 66 shares worth $683. The position accounts for ﹤0.01% of the portfolio, ranked #3612.

Comerica Bank first reported a position in CGEM in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.39K in Q2 2024. 153 funds tracked by Wall St. Rank hold CGEM as of Q4 2025.

Comerica Bank held 66 shares of Cullinan Oncology worth $683 as of Q4 2025.
Comerica Bank sold 129 Cullinan Oncology shares in Q4 2025, an estimated $1.16K.
Cullinan Oncology made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3612 holding.
Comerica Bank first reported a position in Cullinan Oncology in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Cullinan Oncology position peaked at $2.39K in Q2 2024.
153 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.